No. 20-451

Jane Doe, Individually and as Parent and Guardian of Baby Doe, et al. v. Merck & Co., Inc., et al.

Lower Court: Second Circuit
Docketed: 2020-10-08
Status: Denied
Type: Paid
Response Waived
Tags: citizens-action civil-rights due-process fda-licensing fda-regulation primary-jurisdiction standing thimerosal vaccine-act vaccine-injury vaccine-mandate
Key Terms:
SocialSecurity DueProcess Privacy
Latest Conference: 2020-12-04
Question Presented (from Petition)

I. Should Courts extend the precedent of Jacobson v. Massachusetts, 197 U.S. 11 (1905), for the legal requirement that a vaccine licensed through HHS, that is mandated, be necessary, harm-avoidant, proportional and non-discriminatory, requiring individualized exemptions for those eligible and not suitable for vaccinations?

II. Whether the Second Circuit erred finding plaintiff failed to exhaust remedies for a claim "MMR causes autism," overlooking petitioner had exhausted below on the "MMR\TCV! causes autism" and "TCV causes autism" theories, and demonstrated the reliance necessary to prove fraud, and conspiracy to commit fraud, the Court found was lacking?

III. Whether the Second Circuit erred in declining primary jurisdiction over petitioner's Citizens Action against the Secretary, by creating an exhaustion requirement based on its policy view that FDA is better suited to adjudicate the §31 Citizens Action against the Secretary of HHS?

Question Presented (AI Summary)

Whether courts should extend the precedent of Jacobson v. Massachusetts to require that a mandated vaccine be necessary, harm-avoidant, proportional and non-discriminatory, with individualized exemptions

Docket Entries

2020-12-07
Petition DENIED.
2020-11-17
DISTRIBUTED for Conference of 12/4/2020.
2020-11-06
Waiver of right of respondent United States to respond filed.
2020-10-02
Petition for a writ of certiorari filed. (Response due November 9, 2020)

Attorneys

Jane Doe, individually and as Parent/Guardian of Baby Doe, Baby Doe
Patricia FinnPatricia Finn Attorney. P.C., Petitioner
Merck & Co., Inc., et al.
Jeffrey B. WallActing Solicitor General, Respondent